A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
NCT07517250
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Familial Mediterranean Fever
Still Disease
Systemic Juvenile Idiopathic Arthritis
Adult-Onset Still Disease
Sponsor
Novartis Pharmaceuticals